Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca provides update on Phase III trial of Selumetinib in non-small cell lung cancer
-
H1 2016 Results
-
AstraZeneca files first clinical trial application in Moderna messenger RNA collaboration
-
AstraZeneca’s antibiotic Zavicefta met primary endpoints in Phase III trial for treatment of hospital-acquired pneumonia
-
AstraZeneca receives approval in the EU for Qtern (saxagliptin and dapagliflozin) for treatment of Type 2 diabetes
-
Tagrisso met primary endpoint in phase III 2nd-line lung cancer trial
-
AstraZeneca enters licensing agreements with LEO Pharma in skin diseases
-
New antibiotic Zavicefta approved in the European Union for patients with serious bacterial infections
-
AstraZeneca provides update on Flumist Quadrivalent Vaccine in the US for the 2016-17 influenza season
-
AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines portfolio
Latest articles and press releases
All of our latest press releases and articles are available to explore
